The present-day cardiac catheterization laboratory (CCL) is home to varied practitioners who perform both diagnostic, interventional, and complex invasive procedures. Invasive, non-interventional cardiologists are performing a significant proportion of the work as the CCL environment has evolved. This not only includes those who perform diagnostic-only cardiac catheterization but also heart failure specialists who may be involved in hemodynamic assessment and in mechanical circulatory support and pulmonary hypertension specialists and transplant cardiologists. As such, the training background of those who work in the CCL is varied.
| INTRODUCTION
The breadth of practice of invasive cardiology has grown considerably in recent years. In the era prior to percutaneous coronary intervention (PCI), the cardiac catheterization laboratory (CCL) was primarily a place for hemodynamic examination and coronary angiography. As PCI gained importance in the CCL, the focus turned towards interventional procedures; as such, there has been a focus upon developing quality metrics and necessary guidance for interventional cardiologists. However, the CCL continues to be a place where many practitioners perform invasive, diagnostic procedures; but, not interventional procedures. These physicians are an important part of the CCL team and perform diagnostic procedures such as coronary angiography and hemodynamic evaluations. While most quality metrics in the CCL are directed towards evaluation of patients who undergo interventional procedures, there has not been a focus upon providing these invasive, noninterventional cardiologists, hospital/CCL administrators, and CCL directors a platform for: (1) benchmarking quality for the invasive, noninterventional practice, (2) providing this physician community with guidance towards a patient-centered approach to care, and (3) offering tools to the invasive, noninterventionalists to help their professional growth. This consensus statement aims to establish a foundation upon which the invasive, noninterventional cardiologists can thrive in the CCL environment and work collaboratively with their interventional colleagues while ensuring that the highest quality of care is being delivered to all patients.
| SCOPE OF DOCUMENT
There is clearly a niche in the CCL for proceduralists who evaluate the cardiovascular system through the use of invasive means, but who are not "interventional" cardiologists. Specifically, these "invasive cardiologists" do not perform therapeutic interventional procedures including coronary, peripheral vascular, or structural. There is now considerable overlap between what is purely a diagnostic, and what is considered a therapeutic modality in the CCL. This is particularly evident for those procedures where the diagnostic modality requires instrumentation of the cardiovascular circulation and/or placing a device [e.g., fractional flow reserve (FFR) measurement or intravascular ultrasound (IVUS) imaging]. The scope of this document is to provide guidance and support for invasive noninterventional cardiologists performing these procedures and provide a framework for how this might be done in a collaborative and safe way with back-up from interventional cardiologists when necessary. There are three main types of invasive noninterventional cardiologists that this document addresses: (1) general cardiologists, (2) heart failure/pulmonary hypertension specialists, and (3) interventionally trained physicians who no longer perform interventions but continue to perform invasive diagnostic procedures. Table 1 outlines the major areas of concern and why this document is important and offers proposed solutions. The document also serves as an important guide for hospital/CCL administrators and CCL directors to develop a patient-centered framework around quality assurance for procedures performed by these subsets of cardiologists. The writing committee felt that including trained structural or peripheral specialists/proceduralists who do not perform coronary interventions is beyond the scope of this document. This document reveals areas where this writing committee feels there could be additional clarity regarding training and maintenance of certification standards for various procedures performed in the CCL.
| General cardiologists
As a part of training in general cardiology, all cardiologists are expected to understand the use of, integrate the findings from, and, in most cases, perform, and interpret diagnostic cardiac catheterizations in patients with coronary, valvular, and pericardial disease.
1,2
The writing committee recognizes that the training and completion of a general cardiology fellowship should be adequate to allow for safe and successful performance of a wide range of invasive diagnostic procedures, as well as certain therapeutic procedures (e.g., pericardiocentesis, temporary pacemaker placement).
2 Some cardiologists, trained in diagnostic procedures in the CCL, may continue to perform those procedures when needed as part of their general cardiology practice. While recognizing that at times additional • Multidisciplinary "Heart Team" is strongly encouraged to help evaluate goals of care
• Ability to properly assess and interpret invasive hemodynamic data
• Technical Competencies (Some competencies apply to only specific MCS devices)
• Femoral vascular access
• Large bore sheaths
• Trans-septal techniques
• Placement of large intravascular catheters
• Use of vascular access closure techniques
• Understanding of contraindications to MCS devices
• Ability to treat potential related life-threatening complications
| COCATS 4 task force 10 and training standards
As defined by COCATS 4 Task Force 10, there are three incremental levels of proficiency in cardiac catheterization. 2 It is important to note that regardless of the level of training achieved, the trainee needs to show proficiency in patient care and procedural skills, medical knowledge, systems-based practice, practice-based learning and improvement, professionalism, and interpersonal and communication skills. 7 With level I training, invasive procedures should be limited to cardiac care unit procedures with venous and arterial access and to right heart catheterizations. 2 To practice as an invasive, non-interventional cardiologist after cardiology fellowship, level II training must be completed. 2 Completion of level III training qualifies the cardiologist to perform PCI, however additional training is needed to perform peripheral, carotid, and/or structural heart interventions (i.e., valves, congenital heart) and insertion of MCS devices. 
| Maintenance of procedural proficiency
There is a lack of consensus on the caseload needed to maintain procedural skill competency after completion of training. 9 Data suggest that operator and hospital volumes both play a role in PCI outcomes, although there are no data on the volume-outcome relationship for diagnostic cardiac catheterization (a lower risk procedure) or other invasive non-PCI procedures. 10, 11 The writing committee proposes that the CCL director with a quality oversight committee (QOC)
should determine competency of the proceduralist by performing routine assessment of appropriate use, performance, and interpretation for each procedure, and an assessment by a quality assurance program, outlined later in this document. Routine participation in educational forums including morbidity and mortality (M&M) conference, and relevant CME should be required. These measures will allow the acquisition and maintenance of knowledge and continued competency in performing the related procedures.
There has been an increase in utilization of devices today for the management of heart failure such as biventricular (BiV) pacemakers, implantable cardioverter defibrillators (ICD), implantable hemodynamic monitoring systems, MCS, IVUS for the assessment of coronary arteries postcardiac transplantation, and others. 12 For these reasons, interventional heart failure (IHF) is an emerging field focused on device-based approaches for the treatment of advanced heart failure.
Guidance regarding the scope of this field and the training required is recently being introduced and will have significant implications in the CCL. 13, 14 While delving into the details of the IHF pathway are beyond the scope of this document, this training requires an additional year of advanced heart failure training. Trainees who complete IHF training are generally board-eligible to take the advanced heart failure/transplant medicine Board Examination. The IHF training pathway focuses on invasive approaches for patients with advanced heart failure. 15 For operators interested in electrophysiology procedures, the curriculum requirements for training on BiV and ICD devices must be completed and should comply with COCATS 4 Task Force
(Training in Arrhythmia Diagnosis and Management, Cardiac
Pacing, and Electrophysiology). 16 The writing committee recognizes that there is evolution in the various training pathways and requirements for physicians to perform certain procedures in the CCL environment. For instance, heart failure specialists who have received training outside of formal fellowship training programs might be performing FFR, IVUS, or insertion of acute MCS devices at certain institutions. As such, it is imperative for the CCL Director, in collaboration with both the Medical and Surgical 
Maintenance of proficiency
• Lack of consensus of optimal caseload to maintain procedural skill competency after training • Varying patient volume per operator without oversight of competency may result in more procedural complications and suboptimal patient care
• Routine assessment of appropriate use, performance and interpretation for each procedure should be monitored • Implementation of quality assurance program • Assurance of quality of diagnostic angiograms • Mandated participation in educational forums (i.e., M&M conference, relevant CME) Directors of the Advanced Heart Failure/Transplant program, to formalize a plan based on the local institutional environment to determine and continuously examine competency so that only physicians with the proper training, knowledge, and experience are performing these procedures. Table 3 outlines the areas of concern and proposed solutions for issues related to training and maintenance of proficiency;
however, as stated earlier, the writing committee recommends that appropriate professional societies establish the training standards for these procedures when performed by cardiologists who have not completed a formal interventional training.
| QUALITY OVERSIGHT
As stated in earlier SCAI position papers, it is imperative that CCL implement a continuous quality improvement (CQI) program to monitor process and performance within the CCL. 17 The by comparing site-specific data to benchmark metrics, identifying deficiencies, and establishing an appropriate framework for continuous process improvement and remediation of deficiencies. 18, 19 Table 4 summarizes the main goals of this section of the document.
The assessment of individual physician performance is a responsibility of the QOC. Historically, the quality assurance (QA) evaluation of an individual operator has included a periodic review of randomly selected interventional cases, and a detailed appraisal of all procedures associated with a M&M endpoint. The standards for assessing physician competence in PCI have been established, and the same general framework should be applied to assessing the competency of invasive, noninterventional physicians performing procedures within the CCL. 17, 20 All physicians performing diagnostic coronary angiography, irrespective of interventional credentials, should undergo a periodic review of randomly selected diagnostic catheterization procedures.
This review should include variables ranging from preprocedural planning to postprocedural clinical decision-making. Such a review should be performed quarterly. 17, 20 The assessment of each case begins with preprocedural variables such as appropriate indication and consent for the procedure, proper adjustment of medications (i.e., anticoagulants, metformin), proper medical therapy prior to procedure (antiplatelet, antianginal, and statins), choice of vascular access, and hydration for prevention of renal insufficiency when appropriate. 21 The procedural technique, hemodynamic data, and images should be reviewed to ensure that a high quality study was performed while maximizing patient safety. Finally, the review should assess whether the diagnostic images were interpreted correctly, and determine if appropriate clinical decisions were made based on the data acquired at the time of the procedure.
In addition to random review of diagnostic procedures for QA purposes, all diagnostic angiographic procedures with a postprocedure complication should be reviewed by the QOC. These events include, but are not limited to, death, myocardial infarction, stroke, or transient ischemic attack (TIA), coronary dissection or perforation, coronary embolism (air or thrombus), ventricular arrhythmias, anaphylaxis, access site complications (i.e., retroperitoneal hematoma, pseudoaneurysm formation), and over-sedation requiring reversal agents. 20 In particular, the QOC should evaluate whether the complication was avoidable, recognized promptly, treated appropriately and whether an interventional cardiologist (or surgical subspecialty) was consulted or should have been consulted. Such information is critical for appropriate process improvement to assure the highest level of patient safety. In addition, if procedural technique results in the use of excessive contrast administration or radiation exposure, the QOC should review these cases to determine if these issues could have been avoided. To better facilitate cross-discipline discussion of QA measures, it is reasonable to include a noninterventional physician or IHF specialist on the QOC. When any invasive, noninterventional physician performs intracoronary procedures, the writing committee recommends that an interventional cardiologist should be readily 
| PATIENT CARE RELATED TOPICS

| Preprocedural patient-care issues
There are several preprocedural patient care issues that must be recognized when there is an interaction between an invasive noninterventionalist and an interventionalist, outlined in Table 5 .
It is the responsibility of the invasive noninterventionalist to adequately document symptoms, specific antianginal medications, and other pharmacotherapy of all patients being brought to the CCL for diagnostic procedures. The invasive noninterventional physician should estimate and document the risk/benefit ratio of proceeding with the invasive evaluation and potential interventional procedure based on comorbidities and functional testing. The nuances of these points and other important preprocedural considerations are provided in Table 6 . The SCAI PCI risk calculator and SCAI AUC (for both diagnostic catheterization and coronary revascularization) applications are instrumental in decision-making in the ad hoc setting, and are available on the SCAI website at www.scai.org for download. These tools should be used to standardize the approach.
| Cath lab operations and efficiency
While it may be more efficient for large CCLs with multiple rooms to have cases with a low likelihood of PCI or diagnostic only cases (e.g., right heart catheterizations) triaged to a specific operator, there is potential for schedule disruption and inefficiency involving "two operator" cases, especially in smaller CCLs. This may contribute to variable costs for the institution and introduce delays for patients and paradoxically decrease capacity.
The invasive noninterventional proceduralist needs to assure that the selected interventionalist has the appropriate skill set for the specific task at hand, particularly in complex cases, and strongly consider deferring an ad hoc procedure until a staged later date or possibly later the same day if that is not the case. 22 It is important to minimize the duration and consider the potential consequences of sheath dwell time in such "off the table, same day PCI" cases. Systemic anticoagulation should be administered and in-dwelling sheaths should have pressure lines connected to them in order to minimize complications due to prolonged duration of sheath dwell times. The writing committee recommends that a second interim "time-out"/verbal sign-out between the two involved operators at the time of interventional procedure is critical to maintaining overall CCL quality and patient safety. This is consistent with the The Joint Commission requirement of a formal time-out prior to any procedure. 17 Triaging unassigned patients with a high likelihood of PCI to an interventional operator rather than a noninterventional operator may improve patient flow by minimizing the number of "off the table, same day PCI" cases.
| Process for informed consent and effective communication with patient and family
Informed consent is a critically important issue in cases involving two operators and should follow the principles outlined in the SCAI Code of Ethics (http://www.scai.org/codeofethics/default.aspx). Ideally, the designated potential interventional physician should meet with the • Assurance that Oral anticoagulants (Vitamin K antagonists and novel anticoagulants), phosphodiesterase 5 inhibitors, and metformin (for those with reduced GFR) have not been administered within the prespecified time prior to the procedure, unless clinical reasons dictate otherwise
• Knowledge of parenteral heparin (unfractionated or low-molecular weight) last dosage
• Assurance that ASA/P2Y12 receptor inhibitors/statins administered and timing
• Knowledge of patient specific absolute/relative contraindications to prolonged DAPT that might influence choice of stent (bare metal stent vs. drug eluting stent vs. bioresorbable vascular scaffold)
• Knowledge of pharmacokinetics of P2Y12 receptor inhibitors and contraindications for prasugrel (prior TIA/CVA), ticagrelor (prior CNS hemorrhage, liver disease)
• Not administering systemic anticoagulation with either heparin or direct thrombin inhibitors until interventionalist has reviewed the case and agreed to proceed with ad hoc PCI unless required for IVUS or FFR procedures
• Preprocedural assessment of PCI risk (contrast induced nephropathy, bleeding, mortality) and anticipated AUC (absent the final element of intraprocedural angiographic data) for PCI/revascularization
• Direct communication between the interventionalist and noninvasive physician regarding all the items to mitigate errors of commission patient and family members prior to the procedure. When this is not possible, the invasive noninterventionalist is obligated to include in the consent process that another individual with interventional training may be involved in their care and discuss the relevant issues regarding PCI. The writing committee emphasizes the fact that ad hoc PCI is not a fait accompli, and that several situations may preclude this in the general interest of patient safety and shared decision making.
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| Procedural patient-care issues
Specific issues may arise in the care of patients by invasive noninterventionalists (Table 7) . Vascular access and closure remain fundamental aspects of the cardiac catheterization procedure. Working in the contemporary CCL requires familiarity with radial access, large bore vascular access, and an array of vascular closure devices. [23] [24] [25] Ideally, the invasive noninterventional and the interventional Table 8 .
| Procedure report
A preliminary procedure report should be generated immediately 
| Appropriate monitoring and length of stay
The interventional cardiologist should discuss with the invasive noninterventionalist cardiologist the duration of observation, the length of stay after PCI and the appropriateness of same-day discharge, which will depend on access site complications, patient comorbidities, and the need for further management. 28 The chart should clearly delineate the primary physician or advanced practice provider charged with caring for the patient during the observation and/or hospitalization period and which provider will be providing discharge and follow-up instructions.
| Discharge instructions
The interventional cardiologist should discuss and document the duration and type of dual antiplatelet therapy (DAPT) with the invasive noninterventionalist cardiologist and the patient. 29 The physician discharging the patient should perform medication reconciliation, stress the need of DAPT adherence, discuss the expected duration of DAPT or "triple therapy" (antiplatelets + anticoagulants) if needed. 30, 31 Patients previously on warfarin, LMWH or target-specific oral anticoagulants should receive specific instructions when to restart their regimen and when to obtain follow-up PT/INR. The discharging physician should also provide instructions to patients regarding limitations of physical activity, driving, and instructions for the follow-up appointment in addition to discussion regarding secondary prevention measures and referral to cardiac rehabilitation.
Recent evidence demonstrates that same-day discharge is safe in selected patients and is associated with significant cost savings, improved patient satisfaction, and increased bed availability. [32] [33] [34] With respect to PCI patients who are observed overnight, an analysis of the NCDR CathPCI registry demonstrated that from 2009 to 2014, the proportion of outpatients not admitted to a hospital after PCI increased from 32.8% to 66.3%, with admitted patients being older, having more comorbidities, and having experienced post-PCI complications. 35 However, of the patients who were not admitted, those who were at high risk for predicted mortality increased significantly 
